These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 21439024)
1. Antiandrogenic activity of anthranilic acid ester derivatives as novel lead structures to inhibit prostate cancer cell proliferation. Roell D; Rösler TW; Degen S; Matusch R; Baniahmad A Chem Biol Drug Des; 2011 Jun; 77(6):450-9. PubMed ID: 21439024 [TBL] [Abstract][Full Text] [Related]
2. Halogen-substituted anthranilic acid derivatives provide a novel chemical platform for androgen receptor antagonists. Roell D; Rösler TW; Hessenkemper W; Kraft F; Hauschild M; Bartsch S; Abraham TE; Houtsmuller AB; Matusch R; van Royen ME; Baniahmad A J Steroid Biochem Mol Biol; 2019 Apr; 188():59-70. PubMed ID: 30615932 [TBL] [Abstract][Full Text] [Related]
3. The culinary-medicinal mushroom Coprinus comatus as a natural antiandrogenic modulator. Dotan N; Wasser SP; Mahajna J Integr Cancer Ther; 2011 Jun; 10(2):148-59. PubMed ID: 21147815 [TBL] [Abstract][Full Text] [Related]
4. Growth inhibitory, antiandrogenic, and pro-apoptotic effects of punicic acid in LNCaP human prostate cancer cells. Gasmi J; Sanderson JT J Agric Food Chem; 2010 Dec; 58(23):12149-56. PubMed ID: 21067181 [TBL] [Abstract][Full Text] [Related]
5. Extracts from Pygeum africanum and other ethnobotanical species with antiandrogenic activity. Schleich S; Papaioannou M; Baniahmad A; Matusch R Planta Med; 2006 Jul; 72(9):807-13. PubMed ID: 16783690 [TBL] [Abstract][Full Text] [Related]
6. Activity-guided isolation of an antiandrogenic compound of Pygeum africanum. Schleich S; Papaioannou M; Baniahmad A; Matusch R Planta Med; 2006 May; 72(6):547-51. PubMed ID: 16773539 [TBL] [Abstract][Full Text] [Related]
7. Saw Palmetto induces growth arrest and apoptosis of androgen-dependent prostate cancer LNCaP cells via inactivation of STAT 3 and androgen receptor signaling. Yang Y; Ikezoe T; Zheng Z; Taguchi H; Koeffler HP; Zhu WG Int J Oncol; 2007 Sep; 31(3):593-600. PubMed ID: 17671686 [TBL] [Abstract][Full Text] [Related]
8. Antiandrogenic effects of novel androgen synthesis inhibitors on hormone-dependent prostate cancer. Long BJ; Grigoryev DN; Nnane IP; Liu Y; Ling YZ; Brodie AM Cancer Res; 2000 Dec; 60(23):6630-40. PubMed ID: 11118046 [TBL] [Abstract][Full Text] [Related]
9. NBBS isolated from Pygeum africanum bark exhibits androgen antagonistic activity, inhibits AR nuclear translocation and prostate cancer cell growth. Papaioannou M; Schleich S; Roell D; Schubert U; Tanner T; Claessens F; Matusch R; Baniahmad A Invest New Drugs; 2010 Dec; 28(6):729-43. PubMed ID: 19771394 [TBL] [Abstract][Full Text] [Related]
11. Antiandrogenic, maspin induction, and antiprostate cancer activities of tanshinone IIA and its novel derivatives with modification in ring A. Liu W; Zhou J; Geng G; Shi Q; Sauriol F; Wu JH J Med Chem; 2012 Jan; 55(2):971-5. PubMed ID: 22175694 [TBL] [Abstract][Full Text] [Related]
12. Antiproliferative, antiandrogenic and cytotoxic effects of novel caffeic acid derivatives in LNCaP human androgen-dependent prostate cancer cells. Sanderson JT; Clabault H; Patton C; Lassalle-Claux G; Jean-François J; Paré AF; Hébert MJ; Surette ME; Touaibia M Bioorg Med Chem; 2013 Nov; 21(22):7182-93. PubMed ID: 24080105 [TBL] [Abstract][Full Text] [Related]
13. Antiandrogenic activities of diesel exhaust particle extracts in PC3/AR human prostate carcinoma cells. Kizu R; Okamura K; Toriba A; Mizokami A; Burnstein KL; Klinge CM; Hayakawa K Toxicol Sci; 2003 Dec; 76(2):299-309. PubMed ID: 12970580 [TBL] [Abstract][Full Text] [Related]
14. Effect of permixon on human prostate cell growth: lack of apoptotic action. Hill B; Kyprianou N Prostate; 2004 Sep; 61(1):73-80. PubMed ID: 15287095 [TBL] [Abstract][Full Text] [Related]
15. Compounds from Wedelia chinensis synergistically suppress androgen activity and growth in prostate cancer cells. Lin FM; Chen LR; Lin EH; Ke FC; Chen HY; Tsai MJ; Hsiao PW Carcinogenesis; 2007 Dec; 28(12):2521-9. PubMed ID: 17942463 [TBL] [Abstract][Full Text] [Related]
16. Piper cubeba targets multiple aspects of the androgen-signalling pathway. A potential phytotherapy against prostate cancer growth? Yam J; Kreuter M; Drewe J Planta Med; 2008 Jan; 74(1):33-8. PubMed ID: 18080233 [TBL] [Abstract][Full Text] [Related]
17. Novel C-17-heteroaryl steroidal CYP17 inhibitors/antiandrogens: synthesis, in vitro biological activity, pharmacokinetics, and antitumor activity in the LAPC4 human prostate cancer xenograft model. Handratta VD; Vasaitis TS; Njar VC; Gediya LK; Kataria R; Chopra P; Newman D; Farquhar R; Guo Z; Qiu Y; Brodie AM J Med Chem; 2005 Apr; 48(8):2972-84. PubMed ID: 15828836 [TBL] [Abstract][Full Text] [Related]
18. 3 beta-acetoxyandrost-1,5-diene-17-ethylene ketal functions as a potent antiandrogen with marginal agonist activity. Miyamoto H; Marwah P; Marwah A; Lardy H; Chang C Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4440-4. PubMed ID: 12672951 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of the DHT-induced PSA secretion by Verbascum xanthophoeniceum and Serenoa repens extracts in human LNCaP prostate epithelial cells. Marcoccia D; Georgiev MI; Alipieva KI; Lorenzetti S J Ethnopharmacol; 2014 Aug; 155(1):616-25. PubMed ID: 24928827 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of MAPK-signaling pathway promotes the interaction of the corepressor SMRT with the human androgen receptor and mediates repression of prostate cancer cell growth in the presence of antiandrogens. Eisold M; Asim M; Eskelinen H; Linke T; Baniahmad A J Mol Endocrinol; 2009 May; 42(5):429-35. PubMed ID: 19223455 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]